Espicom Business Intelligence Ltd, June 2010, Pages: 248
profitable in India. However, whether the Indianindustry will be able to maintain the pace of expansion across the world is questionable in the current economic climate. The IndianPharmaIndustry - looking
Decision Resources, Inc., Sep 2007, Pages: 23
for blockbuster drugs until a clearer strategy for defending patents emerges from the Indian court system. Which current pharmaceutical patent battle is being closely monitored as a litmus test of Indian courts
CYGNUS Business Consulting & Research, Nov 2010, Pages: 101
applications approved
Figure 3: Trends in PharmaIndustry
Figure 4: Need for CRAMS in Pharmaindustry
Figure 5: Sourcing opportunity evaluation by pharma companies
Figure 6: Post-2005 R&D strategies of Indian
GBI Research, Nov 2010, Pages: 65
, implementation and monitoring of the majority of the government's initiatives has been handled by Council of Scientific and Industrial Research (CSIR). The department established several bodies, such as the Drug
Markets and Markets, April 2010, Pages: 118
7.18 Shreya Life Sciences Pvt Ltd
7.19 Sun PharmaIndustries Ltd
7.20 Takeda Pharmaceuticals Company
7.21 Zydus Cadila Healthcare Ltd
List Of Tables:
Summary Table Bric Diabetes Drugs
Bizacumen Inc., Nov 2009, Pages: 198
with Abbott 20
Roche Signs Marketing Agreement with Mankind Pharma 20
FDA Grants Approval to Abbott Glucose Monitoring System 21
ACCU-CHEK® Aviva
Global Industry Analysts, Inc., Oct 2011, Pages: 446
volume of self-monitoring blood glucose meters and strips continued to remain upbeat.
As stated by Global Industry Analysts's market research report on Blood Glucose Meters and Strips, the US continues
Burrill & Company, April 2011, Pages: 370
Generic
Pharmaceutical Sales 6.80 Indian Pharmaceutical Industry Growth
6.81 Pharma Looks to India: Select Partnering and Licensing Deals in 2010
6.82 Select 2010 Indian Life Sciences M&A
MALAySIA
6
Global Industry Analysts, Inc., Feb 2010, Pages: 893
The Medicines Company Wins FDA Approval for Cleviprex II-38
Indian Pharmaceuticals Wins Approval for Propranolol
Hydrochloride Tablets II-38
Aurobindo Pharma Secures FDA Approval for Lotensin Generic II-38
Zydus
Global Industry Analysts, Inc., Oct 2008, Pages: 455
many key and niche players worldwide such as Criterium, Inc., Covance, Inc., Encorium Group, Inc., ICON PLC, Covalent Group, Inc., Kendle, Life Sciences Research, Inc., MDS Pharma Services, MPI
Global Industry Analysts, Inc., Oct 2010, Pages: 850
key and niche players such as Abbott Laboratories, Astellas Pharma, Inc., Bayer HealthCare AG, Bristol-Myers Squibb Co., Cubist Pharmaceuticals, Inc., Daiichi Sankyo Company, Limited, Eli Lilly and Co
Global Industry Analysts, Inc., Oct 2008, Pages: 239
Strategic Development III-62
Industry Activity in the Recent Past III-63
Key Player III-63
B.Market Analytics III-64
Table 60: Rest of Europe Recent Past, Current and Future
Analysis for HbA1c Monitoring
Business Insights, June 2009, Pages: 287
of major disease
Pharmaceutical market
Biotechnology market
CRO market
Clinical trial market
Geographic focus of the Indian clinical research industry
Market drivers
Population ethnicity and genetic
Business Insights, June 2009, Pages: 149
market
Geographic focus of the Indian clinical research industry
Market drivers
Population ethnicity and genetic diversity
Large complement of trained medical specialists in India
Significant cost savings
RNCOS E-Services Private Limited, Feb 2007, Pages: 90
The report “Indian Biotechnology Market Outlook (2006)” provides an updated and detailed overview of the Indian Biotechnology industry. It examines the emerging trends and provides exclusive
Global Industry Analysts, Inc., Oct 2011, Pages: 365
.
As stated by Global Industry Analysts's new market research report on Anti-Obesity Drugs, the US continues to remain the largest and the fastest growing regional market. The US is home to the majority
TriMark Publications, Nov 2011, Pages: 189
that are utilized in hospitals, clinics, commercial laboratories and research institutions to detect cells and proteins for the purpose of diagnosis and monitoring of disease. This study includes all of the generally
Business Monitor International, Feb 2010, Pages: 87
Business Monitor International's Australia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government
Business Monitor International, Jan 2010, Pages: 75
terms and 8.14% in US dollar terms. In August 2009, continuing with its global expansion, Indian drugmaker Bal Pharma revealed plans to increase its presence in the Chilean drug market via the sale of its
